JPS55501025A - - Google Patents

Info

Publication number: JPS55501025A
Authority: JP; Japan
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Pending

Application number

JP50190279A

Other languages

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1978-10-19

Filing date

1979-10-18

Publication date

1980-11-27

1979-10-18 Application filed filed Critical

1980-11-27 Publication of JPS55501025A publication Critical patent/JPS55501025A/ja

Status Pending legal-status Critical Current

Links

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D489/00—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
- C07D489/06—Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with a hetero atom directly attached in position 14
- C07D489/08—Oxygen atom

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Polarising Elements (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

JP50190279A 1978-10-19 1979-10-18 Pending JPS55501025A (cs)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US95305678A	1978-10-19	1978-10-19

Publications (1)

Publication Number	Publication Date
JPS55501025A true JPS55501025A (cs)	1980-11-27

Family

ID=25493512

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
JP50190279A Pending JPS55501025A (cs)	1978-10-19	1979-10-18

Country Status (16)

Country	Link
JP (1)	JPS55501025A (cs)
AU (1)	AU5189779A (cs)
BE (1)	BE879494A (cs)
CA (1)	CA1108132A (cs)
CS (1)	CS211364B2 (cs)
DK (1)	DK258280A (cs)
ES (1)	ES485154A1 (cs)
FI (1)	FI793235A7 (cs)
FR (1)	FR2439201A1 (cs)
GB (1)	GB2049680A (cs)
IL (1)	IL58489A0 (cs)
IT (1)	IT7969032A0 (cs)
NL (1)	NL7920126A (cs)
NO (1)	NO793297L (cs)
SE (1)	SE8004454L (cs)
WO (1)	WO1980000841A1 (cs)

Families Citing this family (35)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US4795813A (en) *	1981-08-17	1989-01-03	The Florida Board Of Regents On Behalf Of The Florida State University	Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US5668285A (en) *	1986-10-31	1997-09-16	The United States Of America As Represented By The Department Of Health And Human Services	Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
FR2636330B1 (fr) *	1988-09-13	1990-11-30	Sanofi Sa	Procede de preparation de derives de morphinane
DE69033035T2 (de) *	1989-10-16	1999-08-05	The United States of America, represented by the Secretary, U.S. Department of Commerce, Washington, D.C.	Totale synthese von northebain-, normorphin-, noroxymorphon-enantiomeren und -derivaten via n-nor-zwischenverbindungen
US8329216B2 (en)	2001-07-06	2012-12-11	Endo Pharmaceuticals Inc.	Oxymorphone controlled release formulations
KR20030034171A (ko)	2001-07-06	2003-05-01	엔도 파마슈티걸즈, 인크.	옥시모르폰 제어 방출 제형
DK1404331T3 (da)	2001-07-06	2008-01-28	Penwest Pharmaceuticals Co	Sustained release-formuleringer af oxymorphon
US7776314B2 (en)	2002-06-17	2010-08-17	Grunenthal Gmbh	Abuse-proofed dosage system
US20070048228A1 (en)	2003-08-06	2007-03-01	Elisabeth Arkenau-Maric	Abuse-proofed dosage form
DE10336400A1 (de)	2003-08-06	2005-03-24	Grünenthal GmbH	Gegen Missbrauch gesicherte Darreichungsform
DE10361596A1 (de)	2003-12-24	2005-09-29	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
DE102005005446A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Bruchfeste Darreichungsformen mit retardierter Freisetzung
DE102004032049A1 (de)	2004-07-01	2006-01-19	Grünenthal GmbH	Gegen Missbrauch gesicherte, orale Darreichungsform
DE102005005449A1 (de)	2005-02-04	2006-08-10	Grünenthal GmbH	Verfahren zur Herstellung einer gegen Missbrauch gesicherten Darreichungsform
JP5695296B2 (ja)	2006-03-02	2015-04-01	マリンクロッドエルエルシー	低レベルのアルファ，ベータ−不飽和ケトン化合物を伴うモルフィナン−６−オン生成物の製造方法
TWI454288B (zh)	2008-01-25	2014-10-01	Gruenenthal Chemie	藥物劑型
ES2599031T3 (es)	2008-05-09	2017-01-31	Grünenthal GmbH	Proceso para la preparación de una formulación de polvo intermedia y una forma de dosificación solida final utilizando un paso de congelación por pulverización
BR112012001466A2 (pt)	2009-07-22	2020-08-11	Grünenthal GmbH	forma de dosagem resistente à falsificação para opioides sensíveis à oxidação, seu processo de fabricação, e embalagem
ES2534908T3 (es)	2009-07-22	2015-04-30	Grünenthal GmbH	Forma de dosificación de liberación controlada extruida por fusión en caliente
CA2808219C (en)	2010-09-02	2019-05-14	Gruenenthal Gmbh	Tamper resistant dosage form comprising inorganic salt
WO2012028318A1 (en)	2010-09-02	2012-03-08	Grünenthal GmbH	Tamper resistant dosage form comprising an anionic polymer
JP6063462B2 (ja)	2011-07-29	2017-01-18	グリュネンタール・ゲゼルシャフト・ミト・ベシュレンクテル・ハフツング	即時薬剤放出を提供するタンパーレジスタント錠剤
BR112014002022A2 (pt)	2011-07-29	2017-02-21	Gruenenthal Gmbh	comprimido resistente à violação proporcionando liberação de fármaco imediata
BR112014019988A8 (pt)	2012-02-28	2017-07-11	Gruenenthal Gmbh	Forma de dosagem resistente a socamento compreendendo um composto farmacologicamente ativo e um polímero aniônico
LT2838512T (lt)	2012-04-18	2018-11-12	GrĆ¼nenthal GmbH	Pažeidimui atspari ir dozės atpalaidavimo nuokrypiui atspari farmacinė vaisto forma
US10064945B2 (en)	2012-05-11	2018-09-04	Gruenenthal Gmbh	Thermoformed, tamper-resistant pharmaceutical dosage form containing zinc
MX2015016254A (es)	2013-05-29	2016-04-20	Gruenenthal Gmbh	Forma de dosificacion resistente al uso indebido con perfil de liberacion bimodal.
AU2014273227B2 (en)	2013-05-29	2019-08-15	Grunenthal Gmbh	Tamper-resistant dosage form containing one or more particles
AU2014289187B2 (en)	2013-07-12	2019-07-11	Grunenthal Gmbh	Tamper-resistant dosage form containing ethylene-vinyl acetate polymer
HK1224189A1 (zh)	2013-11-26	2017-08-18	Grünenthal GmbH	通过低温研磨制备粉状药物组合物
WO2015173195A1 (en)	2014-05-12	2015-11-19	Grünenthal GmbH	Tamper resistant immediate release capsule formulation comprising tapentadol
US9872835B2 (en)	2014-05-26	2018-01-23	Grünenthal GmbH	Multiparticles safeguarded against ethanolic dose-dumping
WO2016170097A1 (en)	2015-04-24	2016-10-27	Grünenthal GmbH	Tamper-resistant dosage form with immediate release and resistance against solvent extraction
CA2998259A1 (en)	2015-09-10	2017-03-16	Grunenthal Gmbh	Protecting oral overdose with abuse deterrent immediate release formulations
EP3252055B1 (en)	2016-05-31	2018-09-19	Alcaliber Investigacion Desarrollo e Innovacion SLU	Process for obtaining 3,14-diacetyloxymorphone from oripavine

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US3249616A (en) *		1966-05-03		Ix-dfflydroxy-g-oxo-n-phenethylmor- phinan (cis) and production thereof
US2806033A (en) *	1955-08-03	1957-09-10	Lewenstein	Morphine derivative
US3775414A (en) *	1972-05-10	1973-11-27	Bristol Myers Co	Process for the preparation of 14-hydroxymorphinan derivatives

1979
- 1979-10-12 NO NO793297A patent/NO793297L/no unknown
- 1979-10-18 JP JP50190279A patent/JPS55501025A/ja active Pending
- 1979-10-18 AU AU51897/79A patent/AU5189779A/en not_active Abandoned
- 1979-10-18 BE BE0/197710A patent/BE879494A/fr unknown
- 1979-10-18 WO PCT/US1979/000862 patent/WO1980000841A1/en not_active Ceased
- 1979-10-18 GB GB8014422A patent/GB2049680A/en not_active Withdrawn
- 1979-10-18 IL IL58489A patent/IL58489A0/xx unknown
- 1979-10-18 CA CA337,908A patent/CA1108132A/en not_active Expired
- 1979-10-18 NL NL7920126A patent/NL7920126A/nl unknown
- 1979-10-18 FR FR7925895A patent/FR2439201A1/fr not_active Withdrawn
- 1979-10-18 FI FI793235A patent/FI793235A7/fi not_active Application Discontinuation
- 1979-10-18 ES ES485154A patent/ES485154A1/es not_active Expired
- 1979-10-18 IT IT7969032A patent/IT7969032A0/it unknown
- 1979-10-19 CS CS797115A patent/CS211364B2/cs unknown
1980
- 1980-06-16 SE SE8004454A patent/SE8004454L/xx not_active Application Discontinuation
- 1980-06-17 DK DK258280A patent/DK258280A/da unknown

Also Published As

Publication number	Publication date
NL7920126A (nl)	1980-08-29
NO793297L (no)	1980-04-22
CS211364B2 (en)	1982-02-26
DK258280A (da)	1980-06-17
SE8004454L (sv)	1980-06-16
BE879494A (fr)	1980-02-15
IT7969032A0 (it)	1979-10-18
ES485154A1 (es)	1980-06-16
CA1108132A (en)	1981-09-01
FI793235A7 (fi)	1981-01-01
FR2439201A1 (fr)	1980-05-16
WO1980000841A1 (en)	1980-05-01
GB2049680A (en)	1980-12-31
AU5189779A (en)	1980-04-24
IL58489A0 (en)	1980-01-31

Publication	Publication Date	Title
FR2416095B1 (cs)	1983-10-28
FR2414614B1 (cs)	1983-02-04
FR2416466B1 (cs)	1983-06-24
FR2414185B1 (cs)	1980-07-11
AU3898778A (cs)	1978-09-28
FR2416791B1 (cs)	1981-12-11
AU3803078A (cs)	1978-09-04
FR2413960B1 (cs)	1980-05-16
AU3892778A (cs)	1978-10-13
AU73950S (cs)	1978-04-07
BG25902A1 (cs)	1979-01-12
BG25849A1 (cs)	1979-01-12
BG26022A1 (cs)	1979-02-15
BG26009A1 (cs)	1979-02-15
BG25858A1 (cs)	1979-01-12
BG25940A1 (cs)	1979-01-12
BG26061A1 (cs)	1979-02-15
BG26006A1 (cs)	1979-02-15
BG25898A1 (cs)	1979-01-12
BG25955A1 (cs)	1979-01-12
BG25921A1 (cs)	1979-01-12
BG26014A1 (cs)	1979-02-15
BG25842A1 (cs)	1979-01-12
BG25836A1 (cs)	1979-01-12
BG25972A1 (cs)	1979-01-12